These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14762610)

  • 21. [Immunologic findings and therapeutic results in chronic progressive inner ear hearing loss].
    Kempf HG; Hörnig T
    HNO; 1987 Jan; 35(1):38-42. PubMed ID: 3549637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent sudden sensorineural hearing loss sensitive to transtympanic and systemic steroid treatment: case report.
    Scapa VI; Friedland DR
    Ear Nose Throat J; 2009 Mar; 88(3):E14-9. PubMed ID: 19291620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmunity in sudden sensorineural hearing loss: possible role of anti-endothelial cell autoantibodies.
    Cadoni G; Fetoni AR; Agostino S; De Santis A; Manna R; Ottaviani F; Paludetti G
    Acta Otolaryngol Suppl; 2002; (548):30-3. PubMed ID: 12211354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hearing evaluation of intratympanic methylprednisolone perfusion for refractory sudden sensorineural hearing loss.
    She W; Dai Y; Du X; Yu C; Chen F; Wang J; Qin X
    Otolaryngol Head Neck Surg; 2010 Feb; 142(2):266-71. PubMed ID: 20115986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmune sensorineural hearing loss: clinical course and treatment outcome.
    Loveman DM; de Comarmond C; Cepero R; Baldwin DM
    Semin Arthritis Rheum; 2004 Oct; 34(2):538-43. PubMed ID: 15505769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation and treatment of immune-mediated inner ear disease.
    Welling DB
    Ear Nose Throat J; 1996 May; 75(5):301-5. PubMed ID: 8935529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune sensorineural hearing loss improved by tumor necrosis factor-alpha blockade: a case report.
    Staecker H; Lefebvre PP
    Acta Otolaryngol; 2002 Sep; 122(6):684-7. PubMed ID: 12403135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug therapy of acute inner ear hearing loss in childhood and adolescence].
    Ptok M; Klein R; Ptok A; Berg PA; Zenner HP
    HNO; 1994 Oct; 42(10):636-42. PubMed ID: 7528187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modified Siegel's criteria for sudden sensorineural hearing loss: Reporting recovery outcomes with matched pretreatment hearing grades.
    Cheng YF; Chu YC; Tu TY; Shiao AS; Wu SL; Liao WH
    J Chin Med Assoc; 2018 Nov; 81(11):1008-1012. PubMed ID: 29929833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis and treatment of sensorineural hearing deficits of autoimmune origin].
    Castillo JL; López-Escámez JA
    Acta Otorrinolaringol Esp; 2000; 51(5):433-6. PubMed ID: 11000687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ELISPOT determination of interferon-gamma T-cell frequencies in patients with autoimmune sensorineural hearing loss.
    Solares CA; Tuohy VK
    Methods Mol Biol; 2005; 302():253-60. PubMed ID: 15937357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intratympanic methylprednisolone perfusion remedy refractory sudden sensorineural hearing loss].
    Xie LS; Zhou QQ; Li Q; She WD
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 31(7):496-499. PubMed ID: 29871296
    [No Abstract]   [Full Text] [Related]  

  • 33. Disrupted functional brain connectome in unilateral sudden sensorineural hearing loss.
    Xu H; Fan W; Zhao X; Li J; Zhang W; Lei P; Liu Y; Wang H; Cheng H; Shi H
    Hear Res; 2016 May; 335():138-148. PubMed ID: 26969260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intratympanic methylprednisolone as first-line therapy in sudden sensorineural hearing loss: preliminary results from a case-control series.
    Dallan I; Fortunato S; Casani AP; Panicucci E; Berrettini S; Lenzi R; Nacci A
    J Laryngol Otol; 2011 Oct; 125(10):1004-8. PubMed ID: 21806858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternatives to systemic steroid therapy for refractory immune-mediated inner ear disease: A physiopathologic approach.
    García-Berrocal JR; Ibáñez A; Rodríguez A; González-García JA; Verdaguer JM; Trinidad A; Ramírez-Camacho R
    Eur Arch Otorhinolaryngol; 2006 Nov; 263(11):977-82. PubMed ID: 16802138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validity of the Western blot immunoassay for heat shock protein-70 in associated and isolated immunorelated inner ear disease.
    García Berrocal JR; Ramírez-Camacho R; Arellano B; Vargas JA
    Laryngoscope; 2002 Feb; 112(2):304-9. PubMed ID: 11889388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Necrotizing vasculitis in a patient affected by autoimmune hyperthyroidism treated with propylthiouracil.
    Antonucci A; Bardazzi F; Iozzo I; Patrizi A
    Dermatol Ther; 2010; 23 Suppl 2():S41-3. PubMed ID: 20482568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Binding of serum immunoglobulins to human inner ear tissue in inner ear hearing loss: methodologic limits].
    Gebbers JO; Altermatt HJ; Arnold W; Laissue JA; Pfaltz CR
    HNO; 1987 Dec; 35(12):487-91. PubMed ID: 3323147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological treatment of immune-mediated inner ear disorders. A clinical immunology and audiology survey.
    Veldman JE
    Scand Audiol Suppl; 1986; 26():21-6. PubMed ID: 3472327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune-mediated disorders associated with idiopathic sudden sensorineural hearing loss.
    Toubi E; Ben-David J; Kessel A; Halas K; Sabo E; Luntz M
    Ann Otol Rhinol Laryngol; 2004 Jun; 113(6):445-9. PubMed ID: 15224826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.